Glenmark Pharma informed the bourses today before the market hours that it has received final approval from United States Food & Drug Administration (USFDA) for Tacrolimus capsules USP, 0.5 mg, 1 mg & 5 mg, the generic version of Prograf 1 capsules, 0.5 mg, 1 mg & 5 mg of Astellas Pharma.

As investors continued to book profits, equity mutual funds are witnessing outflows for the fourth straight month. Read on to find out more.

Overall, go with the trend but also maintain a trailing stop-loss on all the long positions as the bears won’t give any invitation before attacking.

SGX Nifty is trading with minor gains of about 33 odd points or 0.28 per cent on Wednesday. The global markets, especially the European markets, closed higher with gains of more than 1 per cent each on Tuesday on the back of optimism over the vaccine development. 

SEBI had recently introduced Flexi-cap as an additional category in equity schemes. Fund houses have started to reclassify their multi-cap schemes. Read on to find out more.

The company’s branded textile & branded apparel segment witnessed good traction in September, owing to the wedding and festive season. Currently, the company is witnessing 85 per cent-90 per cent recovery levels in The Raymond Shop (TRS) network in tier IV-VI markets, mainly driven by reverse migration, good harvest & lower COVID-19 impact.

Sales volume from plywood decreased by 11.8 per cent on a YoY basis but on a QoQ basis, it jumped by 174.5 per cent. Also, sales volume from decorative ply declined by 30.8 per cent on a YoY basis but on a QoQ basis, it jumped by 145.7 per cent.

Considering the daily timeframe, the stock has given a downward sloping trendline breakout. Along with this trendline breakout, the stock has also managed to close above the upper Bollinger band and started band walk, which is a very bullish sign.

The stock has formed a bearish engulfing candlestick pattern on the daily timeframe, which suggests a pause in the uptrend. This pattern is considered to be a bearish reversal pattern and usually occurs at the top of an uptrend.

Capital is scared and has alternative uses and hence, before deploying it, you need to check where you can get the best returns.